Skip to content

Clinical trials

Phase 3 Influenza, Human trials in South Africa

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Influenza, Human Phase: Phase 3 Country / region: South Africa Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20081
20091
20113
20121
20141
20151
20193
20222
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche3
BioCryst Pharmaceuticals2
MedImmune LLC2
Seqirus2
University of Witwatersrand, South Africa2
AstraZeneca1
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1
GlaxoSmithKline1
MDVI, LLC1
Novartis Vaccines1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Influenza, Human17
Cough2
Fever2
Headache2
Nasal Obstruction2
Pharyngitis2
COVID-191
Coronavirus Infections1
Fatigue1
Infections1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.